Detalles de la búsqueda
1.
Relationship between transfusion burden, healthcare resource utilization, and complications in patients with beta-thalassemia in Taiwan: A real-world analysis.
Transfusion
; 61(10): 2906-2917, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34505291
2.
Dosimetry with a clinical linac adapted to FLASH electron beams.
J Appl Clin Med Phys
; 22(6): 50-59, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-34028969
3.
Patient-reported outcomes from a randomized phase II study of the deferasirox film-coated tablet in patients with transfusion-dependent anemias.
Health Qual Life Outcomes
; 16(1): 216, 2018 Nov 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-30453981
4.
New film-coated tablet formulation of deferasirox is well tolerated in patients with thalassemia or lower-risk MDS: Results of the randomized, phase II ECLIPSE study.
Am J Hematol
; 92(5): 420-428, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28142202
5.
Qualitative modification and development of patient- and caregiver-reported outcome measures for iron chelation therapy.
Health Qual Life Outcomes
; 15(1): 129, 2017 Jun 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-28645270
6.
Pion effects in flattening filter-free radiation beams.
J Appl Clin Med Phys
; 16(6): 376385, 2015 11 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-26699592
7.
Influence of patient-reported outcomes on the treatment effect of deferasirox film-coated and dispersible tablet formulations in the ECLIPSE trial: A post hoc mediation analysis.
Am J Hematol
; 94(4): E96-E99, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30663129
8.
Upfront Versus Delayed Systemic Therapy in Patients With Oligometastatic Cancer Treated With SABR in the Phase 2 SABR-5 Trial.
Int J Radiat Oncol Biol Phys
; 118(5): 1497-1506, 2024 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38220069
9.
Should organs at risk (OARs) be prioritized over target volume coverage in stereotactic ablative radiotherapy (SABR) for oligometastases? a secondary analysis of the population-based phase II SABR-5 trial.
Radiother Oncol
; 182: 109576, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36822355
10.
Determining Planning Priorities for SABR for Oligometastatic Disease: A Secondary Analysis of the SABR-COMET Phase II Randomized Trial.
Int J Radiat Oncol Biol Phys
; 114(5): 1016-1021, 2022 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35031340
11.
Treatment With Stereotactic Ablative Radiotherapy for Up to 5 Oligometastases in Patients With Cancer: Primary Toxic Effect Results of the Nonrandomized Phase 2 SABR-5 Clinical Trial.
JAMA Oncol
; 8(11): 1644-1650, 2022 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36173619
12.
Training and Validation of Deep Learning-Based Auto-Segmentation Models for Lung Stereotactic Ablative Radiotherapy Using Retrospective Radiotherapy Planning Contours.
Front Oncol
; 11: 626499, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34164335
13.
Implementation of deep learning-based auto-segmentation for radiotherapy planning structures: a workflow study at two cancer centers.
Radiat Oncol
; 16(1): 101, 2021 Jun 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34103062
14.
Experimental determination of electron source parameters for accurate Monte Carlo calculation of large field electron therapy.
Phys Med Biol
; 50(5): 779-86, 2005 Mar 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-15798254
15.
Template-based breast IMRT planning for increased workload efficiency.
Radiat Oncol
; 8: 67, 2013 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-23514439
16.
Screening of drugs by FRET analysis identifies inhibitors of SARS-CoV 3CL protease.
Biochem Biophys Res Commun
; 333(1): 194-9, 2005 Jul 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-15950190
Resultados
1 -
16
de 16
1
Próxima >
>>